HKU Scholars Hub: Browsing DSpace

Browsing by Author Ramji, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 9 to 15 of 15 < previous

	Title	Author(s)	Issue Date
	Inarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response Proceeding/Conference:Hepatology	Yuen, RMF Elkhashab, M Chen, CY Chen, YF Coffin, CS Fung, SK Greenbloom, S Jang, JW Jeng, WJ Kim, DJ Kim, YJ Kim, W Lee, KS Lim, YS Liu, CJ Ramji, A Iyer, R Macfarlane, C Jackson, K Locarnini, S Afdhal, NH Chan, HLY ACHIEVE STUDY Investigators,	2018
	Inarigivir: a novel RIG-I agonist for chronic hepatitis B Proceeding/Conference:Hepatology International	Macfarlane, C Locarnini, S Jackson, K Walsh, R Edwards, R Hammond, R Coffin, C Elkhashab, M Greenbloom, S Ramji, A Chan, HLY Afdhal, W Kim, N Afdhal, N Yuen, RMF Wong, DKH Lyer, R	2018
	Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients Proceeding/Conference:Journal of Hepatology	Ma, XL Lalezari, J Nguyuen, T Bae, Ho Schiff, ER Fung, S Yuen, RMF Hassanein, T Hann, HW Elkhashab, M Dieterich, D Sulkowski, M Kwo, P Nahass, R Agarwal, K Ramji, A Park, J Ravendhran, N Chan, S Weilert, F Han, SH Ayoub, W Gane, E Jacobson, I Bennett, M Huang, Q Yan, R Huey, V Ruby, E Liaw, S Colonno, R Lopatin, U	2019
	RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection Journal:Clinical Gastroenterology and Hepatology	Seto, WKW Asahina, Y Brown, TT Peng, CY Stanciu, C Abdurakhmanov, D Tabak, F Nguyen, TT Chuang, WL Inokuma, T Ikeda, F Santantonio, TA Habersetzer, F Ramji, A Lau, AH Suri, V Flaherty, JF Wang, H Gaggar, A Subramanian, GM Mukewar, S Brunetto, MR Fung, S Chan, HL	2018
	Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection Journal:Journal of Hepatology	Yuen, RMF Agarwal, K Ma, XL Nguyen, TT Schiff, ER Hann, H-WL Dieterich, DT Nahass, RT Park, JS Chan, S Han, S-H B Gane, EJ Bennett, M Alves, K Evanchik, M Yan, R Huang, Q Lopatin, U Colonno, R Ma, J Knox, SJ Stamm, LM Bonacini, M Jacobson, IM Ayoub, WS Weilert, F Ravendhran, N Ramji, A Kwo, PY Elkhashab, M Hassanein, T Bae, HS Lalezari, JP Fung, SK Sulkowski, MS	2022
	SB 9200 an oral selective immunomodulator is safe and efficacious in treatment-naive, non-cirrhotic HBV patients: Results from Cohort 1 of the ACHIEVE trial Proceeding/Conference:Hepatology	Yuen, RMF Coffin, CS Elkhashab, M Greenbloom, S Ramji, A Chan, HLY Iyer, RP Locarnini, S Macfarlane, C Afdhal, NH Kim, W	2017
	Viral response and safety following discontinuation of treatment with the core inhibitor vebicorvir and a nucleos (t)ide reverse transcriptase inhibitor in patients with HBeAg positive or negative chronic hepatitis B virus infection Proceeding/Conference:Journal of Hepatology	Gane, E SulkowskI, M Ma, X Nguyen, T Hann, HW Hassanein, T Elkhashab, M Chan, S Nahass, R Bennett, M Park, J Jacobson, I Bonacini, M Ma, J Yan, R Knox, SJ Stamm, L Ramji, A Han, SHB Ayoub, W Ravendhran, N Kwo, PY Dieterich, D Bae, H Schiff, ER Lalezari, J Fung, S Yuen, RMF	2021

Showing results 9 to 15 of 15 < previous